Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in ACXP — Acurx Pharmaceuticals, Inc.

CIK 1214717 BOSTON, MA
Back to ACXP Full portfolio

Position in ACXP

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$40,936
-$51,141 QoQ
Shares Held
26,411
+6.4% QoQ
Ownership
0.501%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2
of 19 holders
Holding Since
Mar 2022
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ACXP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. ACXP ranks #484 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in ACXP

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $40,936 26,411
2026-03-31 $92,077 24,819
2025-12-31 $30,917 12,417
2025-06-30 $74,812 146,404
2025-03-31 $66,879 171,487
2024-12-31 $119,250 146,500
2024-09-30 $278,349 146,500
2024-06-30 $292,533 130,015
2024-03-31 $285,062 116,352
2023-12-31 $429,465 112,132
2023-09-30 $132,892 88,595
2023-06-30 $204,799 77,283
2023-03-31 $267,399 77,283
2022-12-31 $307,586 77,283
2022-09-30 $228,723 76,241
2022-06-30 $43,717 11,535
2022-03-31 $35,886 10,941